Natixis Investment Managers International Baxter International Inc Transaction History

Natixis Investment Managers International

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$63.83 - $80.0 $735,959 - $922,400	-11,530 Reduced 27.65%	30,163 $1.94 Million
Q1 2022 May 13, 2022	BUY	$76.85 - $89.45 $3.2 Million - $3.73 Million	41,693 New	41,693 $3.23 Million
Q4 2018 Feb 14, 2019	SELL	$61.45 - $77.8 $771,074 - $976,234	-12,548 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$70.71 - $77.75 $131,167 - $144,226	1,855 Added 17.35%	12,548 $967,000
Q2 2018 Aug 14, 2018	BUY	$63.43 - $75.41 $560,086 - $665,870	8,830 Added 473.97%	10,693 $790,000
Q1 2018 May 15, 2018	BUY	$62.56 - $72.26 $116,549 - $134,620	1,863 New	1,863 $121,000
Q4 2017 Feb 14, 2018	SELL	$61.45 - $66.05 $96,230 - $103,434	-1,566 Closed	0 $0
Q3 2017 Nov 14, 2017	SELL	$59.5 - $64.61 $4,581 - $4,974	-77 Reduced 4.69%	1,566 $98,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,643	1,643 $99,000

989

448M

2.22M

3.04M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $18.1B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Natixis Investment Managers International, based on Form 13F filings with the SEC.

Stay updated on Natixis Investment Managers International with notifications on news.